AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05654454 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bevacizumab
Description: Bevacizumab 15 mg/kg
Study NCT05654454 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab 15 mg/kg
Study NCT05654454 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: Paclitaxel 175 mg/m2
Study NCT05654454 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel 175 mg/m2
Study NCT05654454 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin AUC 6
Study NCT05654454 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin AUC 6
Study NCT05574088 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Apical patency with file
Description: After an informed consent , One group will receive apical patency intervention with k file number 10 while the other will be control group
Study NCT05999500 — intervention group
Intervention type: BEHAVIORAL
Intervention: Temple stay experience
Description: Temple stay experience includes diet and behavior changes, such as vegetarian meals (ex. Balwoo Gongyang), mindful eating, no overeating, meditation, participation in daily monastic tasks.
Study NCT04990752 — intervention group
Intervention type: DRUG
Intervention: ulinastatin
Description: In the ulinastatin group, early application of ulinastatin was performed for inflammation management and organ protection before ECMO initiation.The recommended clinical routine dosage of ulinastatin is 300,000 IU, q8h (continuous administration for more than 5 days).
Study NCT05230212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pecan Breakfast Shake
Description: The pecan breakfast shake contains 68 grams of blended raw pecans. Participants will consume this shake at either visit 1 or visit 2 depending on randomization procedures.
Study NCT05230212 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cream Breakfast Shake
Description: The cream breakfast shake contains 138 grams of heavy whipping cream. Participants will consume this shake at either visit 1 or visit 2 depending on randomization procedures.
Study NCT05965856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BL-B01D1
Description: Administration by intravenous infusion
Study NCT05965856 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SI-B003
Description: Administration by intravenous infusion
Study NCT04860102 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: hands on
Description: Hands-on was defined as involving one hand on the fetal head, applying pressure to control expulsion, with the other hand applying pressure on the maternal perineum
Study NCT05693506 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cooking workshops
Description: Cooking workshop in classic form, i.e. with recipes imposed by the dietician on the participants, or cooking workshops in the form of culinary challenges, i.e. without imposed recipes but according to the creativity of the participants
Study NCT04845178 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABP-450
Description: ABP-450 (prabotulinumtoxinA) contains a 900 kDa botulinum toxin type-A complex produced by the bacterium Clostridium botulinum.
Study NCT04845178 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% sodium chloride, sterile, unpreserved, USP/PhEur
Study NCT06167707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCP-111
Description: Furosemide injection 80 mg/mL, 80 mg SC via autoinjector x 1 dose
Study NCT06167707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furosemide USP
Description: Furosemide injection, USP 10 mg/mL, 40 mg IV over 2 minutes followed by 40 mg 2 hours later
Study NCT05393557 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Upfront preparation of microcirculation to minimize risks of no-reflow and reperfusion injury
Description: Tirofiban (intra-coronary bolus of 25µg/Kg) + Nitroglycerin (intracoronary 100-200 µg) + Verapamil (intracoronary 100-200 µg, yet excluding patients with 2nd or 3rd degree AV block, HR \< 60, or SBP \<100 mmHg) + 2 cycles of intermittent balloon inflation
Study NCT06460896 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: pharmacokinetic study
Description: Multicenter pharmacokinetic study of the bioavailability of four compounds in GBP patients: candesartan, amlodipine, metformin and rosuvastatin.
Study NCT06404151 — intervention group
Intervention type: DEVICE
Intervention: monitoring
Description: rc02, ORI , spO2
Study NCT06576206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bin therapy and finger gnosia
Description: Schedule bin therapy sessions 2-3 times per week at first, increasing the frequency as participants get used to it. Data will be collected twice i.e., at the start of the study and after completion of 6 weeks of treatment by using outcome measure tools
Study NCT05798416 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Exercise under inhalation CO2
Description: Participants perform shuttle walk test at high altitude while using the novel portable device for inhalation of CO2
Study NCT05798416 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Exercise under inhalation ambient air
Description: Participants perform shuttle walk test at high altitude while inhaling ambient air
Study NCT05813158 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Group 1(low concentration-high volume bupivacaine US guided Erector Spinae Plane block)
Description: Patients will preoperatively receive low concentration-high volume ultasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room ) one syringe of 30ml bupivacaine 0.25% {15 ml bupivacaine 0.5% and 15ml normal saline} for each patient
Study NCT05813158 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Group 2(high concentration-low volumecbupivacaine US guided Erector Spinae Plane block)
Description: Patients will preoperatively receive high concentration-low volume ultasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room (one syringe of 15 ml bupivacaine 0.5% {15 ml bupivacaine 0.5% } for each patien).
Study NCT05172661 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated physical-cognitive training
Description: Perform a postural task and a cognitive task at the same time (dual-task model) 70 minutes/session\*2 sessions/week\*6 weeks
Study NCT05172661 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Consecutive physical-cognitive training
Description: Perform a postural task and a cognitive task separately for identical durations 70 minutes/session\*2 sessions/week\*6 weeks
Study NCT05096936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates
Description: The solo Pilates method will be applied twice a week for 12 weeks using the following exercises:~20 Breaths, Double leg stretch, Single leg stretch, Leg circles, Hip lift on ball, Abdominal tightening on ball, Alternating two supports, Side bend, Side kick - side kick, Side kicks, Shell and Swan and Neck pull stretches; in the tenth session, we evolved some exercises: The saw, Swan dive, Book close series, Hip lift on the ball and Front pulls; in the eighteenth session we changed again some exercises for: Leg pull back, Rolling like a Ball, Swimming, Roll over and Leg pull front.
Study NCT05096936 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Photobiomodulation
Description: Applications of FBM or placebo (MR4 ACTIVet PRO Laser Shower Portable, MRM, USA) will last for 115s and will deliver 60 J at each point. The mode of application, with the patient supine on a stretcher, with the grouping probe held stationary in contact with the skin, at a 90-degree angle, in the pubic mound and in the perineum region.
Study NCT05096936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Photobiomodulation
Description: Applications of FBM or placebo (MR4 ACTIVet PRO Laser Shower Portable, MRM, USA) will last for 115s and will deliver 60 J at each point. The mode of application, with the patient supine on a stretcher, with the grouping probe held stationary in contact with the skin, at a 90-degree angle, in the pubic mound and in the perineum region.
Study NCT05588102 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Selective Serotonin Reuptake Inhibitor（SSRIs，Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram）
Description: Subjects in the intervention group received SSRIs antidepressants combined with Electronic cognitive training based on mobile phone platform for 52 weeks (once a day, 60min each time)
Study NCT05588102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitor（SSRIs，Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram）
Description: Subjects in the intervention group received SSRIs antidepressants combined with Electronic cognitive training based on mobile phone platform for 52 weeks (once a day, 60min each time)
Study NCT05629013 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: After-Action Review
Description: After-action reviews, or debriefs, are a relatively simple, inexpensive, and quick, tool to improve learning, performance, and the effectiveness of teams and individuals. After-action reviews are active self-learning processes wherein participants reflect on specific performance episode to actively engage in self-discovery and improve learning in a non-punitive/non-judgmental manner to result in enhanced performance. This proposal aims to apply the team effectiveness intervention of the after-action review (AAR) to the services intervention of the Child and Family Team (CFT) meetings currently used in the CWS.
Study NCT04327986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M7824
Description: Intravenous (IV) on Days 1 and 15 of every cycle
Study NCT06576206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional therapy
Description: schedule conventional therapy with 20-50 minutes of each session with each set comprises of 10-12 repetitions of each exercise
Study NCT04327986 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: M9241
Description: Subcutaneous injection on Day 1 of every cycle
Study NCT04327986 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT
Description: Radiation therapy will be starting on Day 17 (+5 days) of Cycle 1 and continue for 5 consecutive business days.
Study NCT04527861 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single-incision Laparoscopic Surgery
Description: In this group，the surgery is performed through a single incision. The surgeon will adjust surgical position to expose the operative field with the help of gravity. Besides，hand over hand cross and parallel techniques are needed to achieve the SILS. All the other operative procedures are the same as conventional laparoscopic surgery.
Study NCT04527861 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Laparoscopic Surgery
Description: In this group，the surgery is performed through 3-5 ports according to the surgeons habits and specific conditions.
Study NCT05630742 — intervention group
Intervention type: OTHER
Intervention: chronic non-neoplastic pain
Description: comparison of questionnaires scores
Study NCT05198843 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dasatinib
Description: Given PO
Study NCT05198843 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Icosapent Ethyl
Description: Given PO
Study NCT04384939 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: magnetic-end Double-J ureteral stent
Description: * Inserting the ureteral stent with magnet (same process as classic ureteral stent)~* Removing the ureteral stent with magnet without general anaesthesia. Usually, the classic ureteral stent removed during a general anaesthesia.
Study NCT06172725 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dietary and exercise intervention
Description: The healthy older adults will follow a twelve-week high-protein vegetarian diet or high-protein omnivorous diet both in combination with a resistance exercise program.~All participants will receive blended dietary counselling. Blended dietary counselling is based on tele-coaching and face-to-face coaching performed by dieticians.
Study NCT06172725 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary and exercise intervention
Description: The healthy older adults will follow a twelve-week high-protein vegetarian diet or high-protein omnivorous diet both in combination with a resistance exercise program.~All participants will receive blended dietary counselling. Blended dietary counselling is based on tele-coaching and face-to-face coaching performed by dieticians.
Study NCT05096949 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home visit delivery strategy
Description: A nurse will deliver and administer Cabenuva injection at patient's home
Study NCT05278429 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Myosuit robotic device
Description: The Myosuit is a partially soft, exoskeleton-type, wearable robot that supports the synergistic extension of the hip and knee joints.
Study NCT05278429 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Myosuit robotic device
Description: The Myosuit is a partially soft, exoskeleton-type, wearable robot that supports the synergistic extension of the hip and knee joints.
Study NCT04856904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trifarotene Cream
Description: Participants will apply a thin a layer of trifarotene (CD5789) 50 mcg/g cream to the face once daily, in the evening for 24 weeks
Study NCT04856904 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Trifarotene Vehicle Cream
Description: Participants will apply a thin a layer of trifarotene vehicle cream to the face once daily, in the evening for 24 weeks
Study NCT03597594 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anti-thymocyte globulin (rabbit)
Description: given intravenously
Study NCT03597594 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Busulfan
Description: given intravenously
Study NCT03597594 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fludarabine
Description: given intravenously
Study NCT03597594 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thiotepa
Description: given intravenous infusion
Study NCT03597594 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CliniMACS
Description: The mechanism of action of the CliniMACS Cell Selection System is based on magnetic-activated cell sorting (MACS). The CliniMACS device is a powerful tool for the isolation of many cell types from heterogeneous cell mixtures, (e.g. apheresis products). These can then be separated in a magnetic field using an immunomagnetic label specific for the cell type of interest, such as CD3+ human T cells.
Study NCT03597594 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CliniMACS
Description: The mechanism of action of the CliniMACS Cell Selection System is based on magnetic-activated cell sorting (MACS). The CliniMACS device is a powerful tool for the isolation of many cell types from heterogeneous cell mixtures, (e.g. apheresis products). These can then be separated in a magnetic field using an immunomagnetic label specific for the cell type of interest, such as CD3+ human T cells.
Study NCT03597594 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Donor Lymphocyte Infusion
Description: given intravenous infusion
Study NCT04896593 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smartphone App
Description: Smartphone app teaching suicide prevention skills.
Study NCT06045091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human BCMA targeted CAR-NK cells injection
Description: Allogenic genetically modified anti-BCMA CAR transduced NK cells
Study NCT05944146 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: passive leg raising
Description: transfer a patient from semi-recumbent position to supine position with a 45° leg lifting
Study NCT05742451 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: kids yoga
Description: The kids yoga was applied to the intervention group for 8 weeks, once a week (8 sessions), 40 minutes per session, by a yoga instructor occupational therapist.~Kids yoga training included: 5-minute warm-up consisting of jogging, jumping, stretching, relaxation exercises; 20 minutes of asanas (positions) consisting of standing, sitting, prone, supine postures and pranayamas (breathing exercises) consisting of vigorous inspiration and expiration, slow and rhythmic alternating nostril breathing; 10-minute yogic games about balance, reaction time and agility; meditation with focus for 5 minutes with resuscitation techniques.
Study NCT04338295 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tattoo machine (SOL Nova Device)
Description: A SOL Nova Device (brand) tattoo machine will be used to stimulate hair regrowth.
Study NCT05305872 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Gandouling
Description: The experimental group was given gandouling tablet + zinc gluconate simulant; The course of treatment was 24 weeks.
Study NCT05305872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gandouling
Description: The experimental group was given gandouling tablet + zinc gluconate simulant; The course of treatment was 24 weeks.
Study NCT04821206 — intervention group
Intervention type: DRUG
Intervention: DMARDs
Description: New Initiation of a DMARDs
Study NCT04821206 — intervention group
Intervention type: DRUG
Intervention: biologic DMARDs
Description: New Initiation of a biologic DMARDs
Study NCT04821206 — intervention group
Intervention type: DRUG
Intervention: JAK Inhibitor
Description: New Initiation of a JAK Inhibitor
Study NCT05140031 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNE4Adults
Description: It is a clear and concise program, that consists of a manual for the physiotherapist delivering the education and a board game to enhance engagement and participant involvement. It not only provides the physiotherapist with a clear how-to manual but also provides an easy and accessible way for the patient to grasp the difficult and complex concept of pain.
Study NCT05140031 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PNE4Adults
Description: It is a clear and concise program, that consists of a manual for the physiotherapist delivering the education and a board game to enhance engagement and participant involvement. It not only provides the physiotherapist with a clear how-to manual but also provides an easy and accessible way for the patient to grasp the difficult and complex concept of pain.
Study NCT06537349 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3% Diquafosol tetrasodium
Description: 3% Diquafosol tetrasodium eye drops will be used to assess its usefulness in OK lens related dry eye
Study NCT05316012 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smart diapers
Description: Residents receive standard continence care while using the smart diaper (without the alerting system) - fase 1~Diapers are changed as usual, e.g., after morning care, visual soiling, unpleasant odor, saturation, leakage.~Residents receive continence care while using the smart diaper with the alerting system - fase 2
Study NCT05944146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dobutamine
Description: infusion dobutamine
Study NCT04695860 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Burosumab
Description: Q4w, 1mg/kg Body weight, s.c.
Study NCT04762472 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Montelukast Oral Tablet
Description: i) Montelukast 10mg daily (tablet) orally x 26 weeks
Study NCT04762472 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Montelukast Placebo Oral Tablet
Description: i) Placebo (Montelukast identical) tablet 1 daily orally x 26weeks
Study NCT05131191 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CT-FFR measurement
Description: Patients were scanned with ≥ 64 row CT according to standard operating specifications. The software obtains the coronary CT angiography image file through the data communication interface. Based on the image processing algorithm, the centerline and contour of the target vessel can be extracted, and then the target vessel can be reconstructed to obtain the three-dimensional size information of the vessel; Based on hydrodynamics calculation and analysis, the fractional flow reserve (FFR) of each position of the target vessel is measured.
Study NCT05131191 — intervention group
Intervention type: PROCEDURE
Intervention: invasive FFR
Description: Insert the pressure guide wire into the finger guide tube and push the pressure guide wire until the pressure sensor just comes out of the orifice of guiding catheter; Equalize PD and PA values;Push the pressure guide wire to the distal end of the lesion, and record the measured blood vessel and position;Record the resting Pd / PA of the pressure guide wire;Nitroglycerin and adenosine triphosphate were administered intravenously according to standard catheter laboratory specifications to achieve maximum hyperemia;Record the FFR value of the in-stent lesions.
Study NCT05047081 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scoring Your College Goals Workshop
Description: A two-hour virtual college readiness workshop.
Study NCT05047081 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Treatment-As-Usual Group which does not receive the workshop intervention
Study NCT05627882 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Forward viewing endoscope
Description: Additional examination with standard forward viewing endoscope